Pharma giant partners with Durham firm to target sickle cell disease
IMMvention retained rights to use its technology to potentially pursue other targets, such as Parkinson’s or Alzheimer’s ...
The Pharma Letter10h
Novo Nordisk teams up with IMMvention Therapeutix on SCD
USA-based biotech IMMvention Therapeutix yesterday revealed it has entered into a strategic collaboration and license ...
PipelineReview.com4h
Strategic Collaboration with Novo Nordisk to Develop Oral Therapies for Sickle Cell Disease and Other Chronic Diseases
DURHAM, NC, USA I2, 2025 I IMMvention Therapeutix, Inc., an early-stage biotechnology company focused on discovering and developing human ...
pharmaphorum20h
Novo sets aside $1.2bn for rare diseases plant
Novo Nordisk has started building its first brand-new manufacturing facility in Denmark since the millennium, saying it plans to spend around DKK 8.5 billion ($1.2 billion) on the plant.
Bloomberg L.P.23h
Novo Nordisk A/S
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...
workandmoney13h
Most Underrated Inventions of All Time
Some of the best innovations are ones we don't even realize we use every day. These are the most underrated inventions we can't live without. The word “invention” usually brings elite tech inventors ...
beckerspayer23h
Payer Issues Newsletter
To sign up for Becker's Payer Issues E-Newsletter or any of our other E-Newsletters, click here. If you are experiencing difficulty receiving our newsletters, you may ...